Lista de obras - Andrea Marcellusi - Dominio Público Uruguay

A novel method to value real options in health care: the case of a multicohort human papillomavirus vaccination strategy

artículo científico publicado en 2013

Adalimumab in the treatment of immune-mediated diseases

artículo científico

Bilateral Salpingo-Oophorectomy Versus GnRH Analogue in the Adjuvant Treatment of Premenopausal Breast Cancer Patients: Cost-Effectiveness Evaluation of Breast Cancer Outcome, Ovarian Cancer Prevention and Treatment.

artículo científico publicado en 2017

Budget Impact Analysis of Dalbavancin in the Treatment of Acute Bacterial Skin and Skin Structure Infections in Three European Countries

artículo científico publicado en 2020

Burden of Disease of Human Papillomavirus (HPV): Hospitalizations in the Marche and Veneto Regions. An observational study

artículo científico publicado en 2017

Cardiotoxicity related to long-term trastuzumab therapy in metastatic breast cancer: the potential role of treatment duration and cardiac risk factors.

artículo científico publicado en 2015

Cost of poor adherence to anti-hypertensive therapy in five European countries.

artículo científico

Cost-Effectiveness Analysis of Universal Human Papillomavirus Vaccination Using a Dynamic Bayesian Methodology: The BEST II Study

artículo científico publicado en 2015

Direct and Indirect Costs of Immunoglobulin Replacement Therapy in Patients with Common Variable Immunodeficiency (CVID) and X-Linked Agammaglobulinemia (XLA) in Italy

scientific article published on 01 October 2018

Direct and indirect costs associated with respiratory allergic diseases in Italy. A probabilistic cost of illness study

artículo científico publicado en 2015

Early Treatment in HCV: Is it a Cost-Utility Option from the Italian Perspective?

artículo científico publicado en 2016

Economic Burden of Rheumatoid Arthritis in Italy: Possible Consequences on Anti-Citrullinated Protein Antibody-Positive Patients.

artículo científico publicado en 2017

Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data

article

Economic aspects in the management of diabetes in Italy

artículo científico publicado en 2016

Economic burden of diverticular disease: An observational analysis based on real world data from an Italian region

artículo científico publicado en 2017

Economic burden of human papillomavirus-related diseases in Italy

artículo científico publicado en 2012

Economic effects of treatment of chronic kidney disease with low-protein diet.

artículo científico publicado en 2014

Economic evaluation of the treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) from the national payer perspective: introduction of a new treatment to the patient journey. A simulation of three European countries

scientific article published on 04 February 2019

Estimation of the number of HCV-positive patients in Italy

scientific article published on 31 October 2019

Evaluation of quality of life and emotional distress in endometrial cancer patients: a 2-year prospective, longitudinal study.

artículo científico publicado en 2014

Governance of preventive Health Intervention and On time Verification of its Efficiency: the GIOVE Study

artículo científico publicado en 2012

HCV - Estimation of the number of diagnosed patients eligible to the new anti-HCV therapies in Italy.

artículo científico publicado en 2016

Health Data Entanglement and artificial intelligence-based analysis: a brand new methodology to improve the effectiveness of healthcare services.

artículo científico publicado en 2016

Health policy model: long-term predictive results associated with the management of hepatitis C virus-induced diseases in Italy

artículo científico publicado en 2014

Health utilities lost and risk factors associated with HPV-induced diseases in men and women: the HPV Italian collaborative study group

artículo científico publicado en 2014

Hospital costs incurred by the Italian National Health Service for invasive cervical cancer.

artículo científico publicado en 2010

How can the results of Health Technology Assessment (HTA) evaluations applied to vaccinations be communicated to decision-makers and stakeholders? The ISPOR Rome Chapter Project

artículo científico publicado en 2015

Impact of HPV vaccination: health gains in the Italian female population

artículo científico publicado en 2017

Model of Management (Mo.Ma) for the patient with schizophrenia: crisis control, maintenance, relapse prevention, and recovery with long-acting injectable antipsychotics (LAIs).

artículo científico publicado en 2016

Multiple sclerosis in Italy: cost-of-illness study

artículo científico publicado en 2011

Novel health economic evaluation of a vaccination strategy to prevent HPV-related diseases: the BEST study

artículo científico publicado en 2012

Optimization of hepatitis C virus screening strategies by birth cohort in Italy

artículo científico publicado en 2020

Patient adherence to and tolerability of self-administered interferon β-1a using an electronic autoinjection device: a multicentre, open-label, phase IV study

artículo científico publicado en 2012

Population-based frequency assessment of HPV-induced lesions in patients with borderline Pap tests in the Emilia-Romagna Region: the PATER study

artículo científico publicado en 2011

Quality of life and emotional distress in early stage and locally advanced cervical cancer patients: a prospective, longitudinal study.

artículo científico publicado en 2011

Reply to comment on Cost of poor adherence to anti-hypertensive therapy in five European country

artículo científico publicado en 2015

The direct and indirect cost of diabetes in Italy: a prevalence probabilistic approach

artículo científico publicado en 2014

The economic burden of HCV-induced diseases in Italy. A probabilistic cost of illness model.

artículo científico

The economic burden of musculoskeletal disorders on the Italian social security pension system estimated by a Monte Carlo simulation

artículo científico publicado en 2015

The role of tumour necrosis factor in the pathogenesis of immune-mediated diseases

artículo científico

Time trade-off procedure for measuring health utilities loss with human papillomavirus-induced diseases: a multicenter, retrospective, observational pilot study in Italy

artículo científico publicado en 2011

Transparency or proper study valuation procedures missed?

artículo científico publicado en 2013

Treatment plan comparison in acute and chronic respiratory tract diseases: an observational study of doxophylline vs. theophylline

artículo científico publicado en 2017

anti-TNF agents as therapeutic choice in immune-mediated inflammatory diseases: focus on adalimumab.

artículo científico

Lista de obras de Andrea Marcellusi

A novel method to value real options in health care: the case of a multicohort human papillomavirus vaccination strategy

Adalimumab in the treatment of immune-mediated diseases

Bilateral Salpingo-Oophorectomy Versus GnRH Analogue in the Adjuvant Treatment of Premenopausal Breast Cancer Patients: Cost-Effectiveness Evaluation of Breast Cancer Outcome, Ovarian Cancer Prevention and Treatment.

Budget Impact Analysis of Dalbavancin in the Treatment of Acute Bacterial Skin and Skin Structure Infections in Three European Countries

Burden of Disease of Human Papillomavirus (HPV): Hospitalizations in the Marche and Veneto Regions. An observational study

Cardiotoxicity related to long-term trastuzumab therapy in metastatic breast cancer: the potential role of treatment duration and cardiac risk factors.

Cost of poor adherence to anti-hypertensive therapy in five European countries.

Cost-Effectiveness Analysis of Universal Human Papillomavirus Vaccination Using a Dynamic Bayesian Methodology: The BEST II Study

Direct and Indirect Costs of Immunoglobulin Replacement Therapy in Patients with Common Variable Immunodeficiency (CVID) and X-Linked Agammaglobulinemia (XLA) in Italy

Direct and indirect costs associated with respiratory allergic diseases in Italy. A probabilistic cost of illness study

Early Treatment in HCV: Is it a Cost-Utility Option from the Italian Perspective?

Economic Burden of Rheumatoid Arthritis in Italy: Possible Consequences on Anti-Citrullinated Protein Antibody-Positive Patients.

Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data

Economic aspects in the management of diabetes in Italy

Economic burden of diverticular disease: An observational analysis based on real world data from an Italian region

Economic burden of human papillomavirus-related diseases in Italy

Economic effects of treatment of chronic kidney disease with low-protein diet.

Economic evaluation of the treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) from the national payer perspective: introduction of a new treatment to the patient journey. A simulation of three European countries

Estimation of the number of HCV-positive patients in Italy

Evaluation of quality of life and emotional distress in endometrial cancer patients: a 2-year prospective, longitudinal study.

Governance of preventive Health Intervention and On time Verification of its Efficiency: the GIOVE Study

HCV - Estimation of the number of diagnosed patients eligible to the new anti-HCV therapies in Italy.

Health Data Entanglement and artificial intelligence-based analysis: a brand new methodology to improve the effectiveness of healthcare services.

Health policy model: long-term predictive results associated with the management of hepatitis C virus-induced diseases in Italy

Health utilities lost and risk factors associated with HPV-induced diseases in men and women: the HPV Italian collaborative study group

Hospital costs incurred by the Italian National Health Service for invasive cervical cancer.

How can the results of Health Technology Assessment (HTA) evaluations applied to vaccinations be communicated to decision-makers and stakeholders? The ISPOR Rome Chapter Project

Impact of HPV vaccination: health gains in the Italian female population

Model of Management (Mo.Ma) for the patient with schizophrenia: crisis control, maintenance, relapse prevention, and recovery with long-acting injectable antipsychotics (LAIs).

Multiple sclerosis in Italy: cost-of-illness study

Novel health economic evaluation of a vaccination strategy to prevent HPV-related diseases: the BEST study

Optimization of hepatitis C virus screening strategies by birth cohort in Italy

Patient adherence to and tolerability of self-administered interferon β-1a using an electronic autoinjection device: a multicentre, open-label, phase IV study

Population-based frequency assessment of HPV-induced lesions in patients with borderline Pap tests in the Emilia-Romagna Region: the PATER study

Quality of life and emotional distress in early stage and locally advanced cervical cancer patients: a prospective, longitudinal study.

Reply to comment on Cost of poor adherence to anti-hypertensive therapy in five European country

The direct and indirect cost of diabetes in Italy: a prevalence probabilistic approach

The economic burden of HCV-induced diseases in Italy. A probabilistic cost of illness model.

The economic burden of musculoskeletal disorders on the Italian social security pension system estimated by a Monte Carlo simulation

The role of tumour necrosis factor in the pathogenesis of immune-mediated diseases

Time trade-off procedure for measuring health utilities loss with human papillomavirus-induced diseases: a multicenter, retrospective, observational pilot study in Italy

Transparency or proper study valuation procedures missed?

Treatment plan comparison in acute and chronic respiratory tract diseases: an observational study of doxophylline vs. theophylline

anti-TNF agents as therapeutic choice in immune-mediated inflammatory diseases: focus on adalimumab.